High raw material costs dragged Lupin s Q4 net profit to below the Street s estimate, however, the sharp margin improvement provided much cushion to investor sentiment.
Lupin reported a 52% YoY growth in net profit to Rs 368 crore for March 2024 quarter. Revenue increased by 12% to Rs 4,961 crore. The company declared a dividend of Rs 8 per share.
Read more about Lupin shares slide 4% amid profit booking post March quarter results on Business Standard. During the past six trading days, Lupin outperformed the market and surged 15 per cent as compared to a per cent rise in the S&P BSE Sensex till Wednesday
Lupin share falls 3% post Q4 earnings, here s what brokerages say
Share of Lupin fell up to 3.7% to Rs 1165.95 against previous close of Rs 1,210 on BSE
BusinessToday.In | May 14, 2021 | Updated 12:33 IST
Lupin share trades higher than 20 day, 50 day, 100 day and 200 day moving averages but lower than 5 day moving averages.
Lupin share lost over 3% today after the firm reported a 18.15% rise in Q4 net profit. Share of Lupin fell up to 3.7% to Rs 1165.95 against previous close of Rs 1,210 on BSE.
The share trades higher than 20 day, 50 day, 100 day and 200 day moving averages but lower than 5 day moving averages. The share has gained 36.25% in one year and risen 20.37% since the beginning of this year.
Pharma major Lupin reported a net profit of Rs 1,216 crore for the fiscal ended March 2021 against a loss of Rs 269 crore in the previous fiscal. However, total income fell 3.53% to Rs 15,299 crore in FY20-21 against Rs 15,858 crore in FY19-20.